Prevenar 13 indicated in adults
Prevenar 13 (pneumococcal polysaccharide conjugate vaccine; Pfizer) is now indicated for the active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults who are aged 18 years or older and the elderly. Further changes to the summary of product characteristics reflect this addition.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068132
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com